Literature DB >> 15959735

The Geneva and Lausanne (French-speaking Switzerland) experience: in favor of the transsphenoidal approach when feasible.

Benedict Rilliet1, Olivier Vernet, Alessia Pica.   

Abstract

BACKGROUND: The authors present their current attitude towards management of craniopharyngiomas in children. Radical surgery cannot be performed when one is not sure about its potential danger to the visual pathways and the hypothalamus.
METHODS: Most of the surgeries that have been performed in our institution via an intracranial approach were incomplete and followed by radiotherapy, in the last 10 years with stereotactic conformational radiotherapy. DISCUSSION: Considering our past and present experience concerning the transphenoidal approach for treatment of craniopharyngiomas, we make a plea for the consideration of this approach in children whenever feasible (around 25% of the cases in children older than 5 years). Craniopharyngiomas that can be removed by this approach represent a milder form of the disease and the results concerning the visual, hypothalamic functions and quality of life are significantly better than that obtained via an intracranial approach. When the craniopharyngioma cannot be removed by this approach because of tight hypothalamic adherences, the technique of cystosphenoidostomy with a custom-made shunt plus adjuvant stereotactic conformational radiotherapy is an alternative for its total removal.

Entities:  

Mesh:

Year:  2005        PMID: 15959735     DOI: 10.1007/s00381-005-1184-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  7 in total

1.  Craniopharyngiomas, results in children and adolescents operated through a transsphenoidal approach compared with an intracranial approach.

Authors:  B Rilliet; V de Paul Djientcheu; O Vernet; J Montes; J P Farmer; G Bertrand
Journal:  Front Radiat Ther Oncol       Date:  1999

2.  Transsphenoidal microsurgery in the management of craniopharyngioma.

Authors:  E R Laws
Journal:  J Neurosurg       Date:  1980-05       Impact factor: 5.115

Review 3.  The present and future management of childhood craniopharyngioma.

Authors:  R Hayward
Journal:  Childs Nerv Syst       Date:  1999-11       Impact factor: 1.475

4.  Outcome of craniopharyngioma in children: long-term complications and quality of life.

Authors:  Andrea Poretti; Michael A Grotzer; Karin Ribi; Eugen Schönle; Eugen Boltshauser
Journal:  Dev Med Child Neurol       Date:  2004-04       Impact factor: 5.449

5.  20-year experience in childhood craniopharyngioma.

Authors:  S Hetelekidis; P D Barnes; M L Tao; E G Fischer; L Schneider; R M Scott; N J Tarbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-09-30       Impact factor: 7.038

6.  Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted?

Authors:  C J De Vile; D B Grant; B E Kendall; B G Neville; R Stanhope; K E Watkins; R D Hayward
Journal:  J Neurosurg       Date:  1996-07       Impact factor: 5.115

7.  Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma--a 20-year experience.

Authors:  R M Scott; S Hetelekidis; P D Barnes; L Goumnerova; N J Tarbell
Journal:  Pediatr Neurosurg       Date:  1994       Impact factor: 1.162

  7 in total
  3 in total

1.  Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation.

Authors:  Zoran S Gucev; Dragan Danilovski; Velibor Tasic; Jovica Ugrinovski; Vesna Nastova; Aleksandra Jancevska; Marina Krstevska-Konstantinova; Nada Pop-Jordanova; Ilija Kirovski
Journal:  World J Pediatr       Date:  2010-12-30       Impact factor: 2.764

Review 2.  A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma.

Authors:  Aaron J Clark; Tene A Cage; Derick Aranda; Andrew T Parsa; Peter P Sun; Kurtis I Auguste; Nalin Gupta
Journal:  Childs Nerv Syst       Date:  2012-10-23       Impact factor: 1.475

3.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.